Company Filing History:
1 out of 832,912 Years Active: 2015
Title: Hua Yu - Innovator in Antibody-siRNA Conjugate Technology
Introduction
Hua Yu is a notable inventor based in Duarte, California. She has made significant contributions to the field of biotechnology, particularly in the development of antibody-based delivery systems for therapeutic applications.
Latest Patents
Hua Yu holds a patent for a method titled "Humanized lewis-Y specific antibody-based delivery of dicer substrate siRNA (D-siRNA) against STAT3." This innovative patent outlines methods for covalently or non-covalently conjugating an antibody, such as hu3S193, with an siRNA molecule targeting STAT3. The methods include modifying an antibody with a linker to create an antibody-siRNA complex, which can be utilized to suppress or silence STAT3 protein expression in cancer cells.
Career Highlights
Throughout her career, Hua Yu has focused on advancing therapeutic strategies that leverage the power of antibodies and RNA interference. Her work has the potential to impact cancer treatment significantly, providing new avenues for targeted therapy.
Collaborations
Hua Yu has collaborated with esteemed colleagues, including Yuelong Ma and David A. Horne, to further her research and development efforts in this innovative field.
Conclusion
Hua Yu's contributions to antibody-siRNA conjugate technology exemplify the intersection of innovation and therapeutic advancement. Her work continues to pave the way for new cancer treatment methodologies.